Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Accenture, Biocelerate collaborate for biopharmaceutical innovation

Accenture will work with BioCelerate, a subsidiary of TransCelerate BioPharma, a nonprofit focused on improving efficiencies in research and development, to develop a platform enabling its member companies to aggregate and analyze preclinical and clinical information to improve drug development efficiency and bring new medicines to patients faster. “The ability to collect and leverage large amounts […]

The post Accenture, Biocelerate collaborate for biopharmaceutical innovation appeared first on CenterWatch News Online.

Powered by WPeMatico

News

Drug resistance: WHO report ‘serious lack of new antibiotics’

A new report from the WHO reveals that the current scope of new antibiotic development is far from what is needed to tackle drug resistance. Powered by WPeMatico

more >

Kyowa Hakko Kirin joins Certara’s Simcyp consortium

Certara, a provider of model-informed drug development and regulatory science, announced that Kyowa Hakko Kirin has joined the Simcyp Consortium and licensed the Simcyp Population-based Simulator. Kyowa Hakko Kirin is the 36th leading biopharmaceutical company and the 11th Japanese pharmaceutical company to join the Consortium. Member companies meet in a pre-competitive environment and work together to […]

more >

Pharmavize, Crystallics merge, launch Ardena

A new early phase contract development and manufacturing organization (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics.  The two companies came together in 2016 with backing from investor Mentha Capital. The new brand name, Ardena, reveals the increased service offering and complementary capabilities of Pharmavize in Belgium and Crystallics in the Netherlands. […]

more >

Alexion restructures, cuts workforce 20%

Alexion Pharmaceuticals announced an operational plan to re-align the global organization with its refocused corporate strategy. The plan is expected to deliver approximately $270 million in GAAP and approximately $250 million in non-GAAP pre-tax savings annually by 2019. The restructuring will reduce the company’s global workforce by approximately 20%. The resulting savings will allow Alexion […]

more >

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of institutional and private investors. As part of the transaction, ProQR has granted an exclusive license to Amylon to develop therapeutics for beta amyloid related disorders. Amylon […]

more >

James Ostell named National Center for Biotechnology Information director

National Library of Medicine (NLM) Director Patricia Flatley Brennan, R.N., Ph.D., has appointed James M. Ostell, Ph.D., as the director of the National Center for Biotechnology Information (NCBI), a division of NLM at the NIH. Dr. Ostell has been with NCBI since it was established by Congress in 1988, and has helped shape it into one […]

more >